Xue Feng Presented Her Work on AAV Vector–Based Gene Therapy
Sep 29, 2025, 16:19

Xue Feng Presented Her Work on AAV Vector–Based Gene Therapy

Mediamedic shared a post on LinkedIn:

“ISEH 2025 | Professor Xue Feng: AAV Gene Therapy Transforming Hemophilia B Treatment in China

At the 54th Annual Scientific Meeting of ISEH in Kumamoto, Japan, Professor Xue Feng (Institute of Hematology & Blood Diseases Hospital, CAMS) presented her work on AAV vector–based gene therapy expressing Factor IX Padua for Hemophilia B.
In an exclusive interview with Oncology Frontier – Hematology Frontier, she shared the science behind this innovative approach, its clinical potential, and the future of gene therapy development in China.”

Xue Feng Presented Her Work on AAV Vector–Based Gene Therapy

Stay updated with Hemostasis Today.